載入...
Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma
Sorafenib has been demonstrated to improve survival rate in patients with advanced hepatocellular carcinoma (HCC); however, the survival benefit remains modest and the response rates remain poor. Transarterial chemoembolization (TACE) may be used for the treatment of advanced HCC with well-preserved...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4186530/ https://ncbi.nlm.nih.gov/pubmed/25289106 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2014.2512 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|